BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3568913)

  • 1. [Observations on the effect of PZA, EB and RFP on uric acid metabolism].
    Dong SQ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Aug; 9(4):220-2, 254. PubMed ID: 3568913
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperuricaemia induced by ethambutol.
    Narang RK; Agarwal MC; Raina AK; Singh SN; Bihari K; Sharma SN
    Br J Dis Chest; 1983 Oct; 77(4):403-6. PubMed ID: 6639867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 4. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of PZA and EB in short course chemotherapy. Report of the 22nd series of controlled trial of chemotherapy].
    Nagasawa S
    Kekkaku; 1984 Nov; 59(11):575-80. PubMed ID: 6441058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA; Oluboyo PO; Okesina AB
    Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
    Sagalovich VIa; Medunitsyna ND; Andrzheiuk NI; Chelnokova NV; Sagalovich AV
    Probl Tuberk; 1982 Feb; (2):36-41. PubMed ID: 7063477
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arthralgia and uricemia produced by pyrazinamide].
    Ishiguro S
    Kekkaku; 1982 Sep; 57(9):483-90. PubMed ID: 7176304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    MavrotskiÄ­ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperuricemia and arthralgia during pyrazinamide treatment].
    Inoue T; Ikeda N; Kurasawa T; Sato A; Nakatani K; Ikeda T; Yoshimatsu H
    Nihon Kokyuki Gakkai Zasshi; 1999 Feb; 37(2):115-8. PubMed ID: 10214039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the side effects of rifadin and ethambutol].
    Firsova LP; Liuboshenko LA
    Probl Tuberk; 1975; (12):42-5. PubMed ID: 1221423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.